Kingmed Diagnostics' core business segment revolves around providing comprehensive medical diagnostic services. This includes a wide array of laboratory tests spanning various medical disciplines such as clinical chemistry, hematology, microbiology, immunology, and molecular diagnostics. The company leverages advanced technologies and methodologies to ensure accurate and timely results, aiding clinicians in diagnosis, treatment monitoring, and disease prevention. Kingmed's extensive network of laboratories across China enables it to serve a diverse patient population, contributing to improved healthcare outcomes and public health initiatives. The company continuously invests in R&D to expand its test menu and enhance the precision and efficiency of its diagnostic services.

Kingmed Diagnostics offers comprehensive support services for clinical trials, leveraging its extensive laboratory network and expertise in diagnostic testing. This segment provides services such as sample management, biomarker analysis, and data management to pharmaceutical companies and research institutions conducting clinical trials. Kingmed's capabilities in advanced diagnostic technologies, including genomics and proteomics, enable it to support the development of novel therapies and personalized medicine approaches. The company's commitment to quality and regulatory compliance ensures the integrity and reliability of clinical trial data, contributing to the advancement of medical research and the development of innovative treatments.